Avinger announces issuance and allowance of seven u.s. patents

Redwood city, ca / accesswire / may 25, 2021 / avinger, inc. (nasdaq:avgr), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for diagnosis and treatment of peripheral artery disease (pad), today announced the issuance and allowance of seven u.s. patents to date in 2021. these new u.s. patents include a wide range of claims relating to avinger's proprietary optical coherence tomography (oct) intravascular imaging system and its oct-guided catheters for the treatment of vascular disease.
AVGR Ratings Summary
AVGR Quant Ranking